Results 91 to 100 of about 9,475 (246)
Topiramate Monotherapy in Infantile Spasm
Infantile spasm is an age-related refractory epilepsy. Topiramate is a new anticonvulsant with multiple mechanisms of action, and it may be effective for treating pediatric epilepsies. To evaluate the efficacy and tolerability of first-line topiramate treatment for infantile spasm, 20 patients received topiramate monotherapy during this study.
Yong Hoon Jun+3 more
openaire +3 more sources
Open‐label CBD treatment was associated with sustained seizure reduction through 144 weeks, with a consistent safety profile in patients with treatment‐resistant focal epilepsies, regardless of epilepsy type. Abstract Objective Cannabidiol (CBD) treatment was associated with long‐term seizure reduction in patients with various treatment‐resistant ...
Anup D. Patel+8 more
wiley +1 more source
A case of infantile spasms with three possibly pathogenic de novo missense variants in NF1 and GABBR1. [PDF]
Watanabe K+3 more
europepmc +1 more source
Abstract Epilepsy is a chronic neurological condition marked by recurrent, uncontrolled seizures. Identifying comorbidities in epilepsy is critical for preventing mortality. Among these, the autonomic nervous system's role in epilepsy often manifests as cardiac disorders. Patients with epilepsy (PWE), particularly those with poorly controlled seizures,
Enes Akyuz+2 more
wiley +1 more source
Response to sequential treatment with prednisolone and vigabatrin in infantile spasms. [PDF]
Dzau W+6 more
europepmc +1 more source
Treatment of Infantile Spasms: Results of a Population‐Based Study with Vigabatrin as the First Drug for Spasms [PDF]
Marja‐Liisa Granström+2 more
openalex +1 more source
Abstract Objectives Responsiveness to vagus nerve stimulation (VNS) in children with drug‐resistant epilepsy (DRE) is often defined based on reduction in seizure frequency, typically at the 50% threshold, with limited consideration to the effects of therapy on seizure severity and health‐related quality of life (HRQoL). In the current report, we sought
Farbod Niazi+38 more
wiley +1 more source
Abstract Objective Developmental and epileptic encephalopathy type 1 (DEE1) is a rare drug‐resistant pediatric epilepsy caused by trinucleotide repeat expansions in the X‐linked ARX gene, leading to elongation of the first polyalanine tract. It presents with early onset tonic seizures or spasms, developmental and cognition delay, and high risk of ...
Lucia Verrillo+9 more
wiley +1 more source
More Hormones, Less Spasms: IGF-1 as a Potential Therapy for Infantile Spasms. [PDF]
Dang LT.
europepmc +1 more source